Kyowa Kirin International NewCo Sweden AB
Global specialty pharmaceutical company focused on innovative drug development.
Overview
- Unknown
- Employees
- Unknown
- Revenue
- 2023
- Founded
Key Decision Makers
Lee Hyun-hee
Manager
Rachel Soloff
Executive Director of Research
Kazuki Nemoto
Global Legal Head
Ana Bastiani-Posner
Executive Vice President, Chief Financial Officer
+70 more contacts in Funnelfeedr
Description
Kyowa Kirin International NewCo Sweden AB operates as a regional entity within the global network of Kyowa Kirin, a Japan-based specialty pharmaceutical company. This organization is dedicated to the research, development, manufacturing, and marketing of innovative medicines. The company leverages u...
Tags
Keywords
Tech Stack
Company Information
- Industry
- Övrig reklamverksamhet
- Legal Form
- Aktiebolag
- VAT Number
- SE559424688501
Decision Makers
74 contacts in FunnelfeedrLee Hyun-hee
Manager
Rachel Soloff
Executive Director of Research
Kazuki Nemoto
Global Legal Head
Ana Bastiani-Posner
Executive Vice President, Chief Financial Officer
Takeshi Matsushita
Executive Officer, Head of Corporate Planning Department
Hiroshi Komatsu
Full-time Audit & Supervisory Board Member
Patrick Adams
Vice President, North America, Market Access & Pricing
Masashi Miyamoto
Representative Director, Chairman & CEO
Hiroshi Kanno
Outside Director of the Board
Toshiaki Uchikawa
Global International Business Planning Head
Nilay Gami
VP, Global Head of PV Operations & NA Regional Head of PV
Hiroki Nakamura
Global Corporate Communications Head
Joseph Zarkoski
Vice President, North America Quality Assurance
Mitch Katz
Senior Vice President, Global Clinical Operations
Ernesto Aycardi
Chief Development Officer
Kenji Shibata
Global Internal Audit Head
Gunnar Kaufmann
Chief Scientific Officer
Britt Byers
Senior Vice President, Human Resources North America
Hiroshi Sonegawa
Japan Sales & Marketing Head
Yoshihisa Suzuki
Outside Director of the Board
Tomohiro Sudo
Managing Executive Officer, Chief International Business Officer
Daisuke Fujiwara
Director of the Board
Takefumi Matsushita
Global Corporate Planning Head
Yoshifumi Torii
Global Research Head & Global Development Head
Yoko Wachi
Outside Audit & Supervisory Board Member
Hajime Kobayashi
Full-time Outside Audit & Supervisory Board Member
Masahiro Hara
Global Procurement Head
Nathan Hawes
Global Operational and Digital Transformation Head
Hiroshi Sonekawa
Japan Sales & Marketing Head
Naohiko Kubo
Global Finance Head
Hidekuni Kaito
Senior Vice President, North America, Head of GPM/NPP Office
Mayumi Tamura
Outside Audit & Supervisory Board Member
Tara D’Orsi
Executive Vice President, Chief Compliance Officer and General Counsel
Julie Dehaene-Puype
Region President, Europe and the Rest of the World
Rieko Waxman
Executive Vice President, Corporate Planning
Paul Testa
Executive Vice President, Supply Chain and Operations
Toru Ishikura
Audit & Supervisory Board Member
Rumiko Nakata
Outside Director of the Board
Chris Valosky
Vice President, North America, CNS Franchise Head
Jonathan Patroni
Global Quality Assurance Head
Eslie Dennis
Global Head of Medical Affairs
Hideaki Matsumoto
Global Product Strategy Head
Greg Palko
Vice President, North America, Oncology Franchise Head
Steve Schaefer
President, North America
Yukiko Ito
Outside Director
Doug Grant
General Manager, Canada
Mitsuru Kameyama
Executive Officer, Chief Digital Transformation Officer
Masaru Otsuka
Global Information and Communication Technology Head
Abdul Mullick
Representative Director, President & COO
Motohiko Kawaguchi
Chief Financial Officer (CFO)
Takeyoshi Yamashita
Vice President and CMO
Ikuko Okubo
Global Intellectual Property Head
Richard Wilson
Vice President, North America, Rare Disease Franchise Head
Shoko Itagaki
Chief People Officer (CPO) & Global Human Resources Head
Toshiyuki Kurata
Chief Supply Chain Officer (CSCO) & Global Manufacturing Head
Takashi Oyamada
Director of the Board
Simon Dawson
General Manager, Head of APAC Cluster
Kim Ga-won
HR/Office manager
Christina Hardy
Clinical Trial Manager
Yoshiko Mori
Chief Compliance Officer (CCO)
Jeremy Morrissey
Executive Director, North America, Commercial Operations
Takatoshi Uochi
Head of Compliance & Risk Management Department
Atsushi Matsumoto
Global Supply Chain Management Head
Ian Duguid
Global Regulatory Affairs Head
Takaaki Uochi
Global Compliance and Risk Management Head
Yasuo Fujii
Chief Strategy Officer (CSO) & Global BD Head
Liz Butcher
Associate Director Patient Advocacy and Communications
Casilda Barnes
Vice President, Head of Regulatory Affairs
Other Contacts
Sakurako Nagaoka
Global Human Resources
Roshni Patel
Regulatory Affairs
Makoto Higashi
Pharmacovigilance Operations
Hiroshi Yumigeta
Researcher, Safety Research Institute
+2 more contacts in Funnelfeedr
Similar Companies
20 similar companies in Funnelfeedr
AAX Biotech AB
5–9 employeesResearch-driven biotech advancing antibody therapies via proprietary technology.
Triquetra Medicines AB
0 employeesDeveloping innovative, affordable prescription medicines for EU patients.
Alvotech Sweden AB
20–49 employeesDeveloping and manufacturing affordable biosimilars to expand global medicine access.
Purpose Pharma International AB
5–9 employeesDeveloping and supplying rare disease treatments across Europe.
Affibody AB
50–99 employeesDeveloping next-generation radiopharmaceuticals using proprietary Affibody technology.
Kyowa Kirin International NewCo Sweden AB Questions
Want to see Funnelfeedr in action?
Book a free demo and discover how Funnelfeedr helps you find and convert your ideal customers.
Book a demo